RE:RE:RE:RE:AA ?and while the addition of Tecentriq was intrepreted as additive, it still needs to be proven out in a Phase II. This is why Matt stated that addition of a CPI would be done as a post approval activity.
It makes sense, generate a revenue stream, and then adapt the combination to entice a Big Pharma buyer/partner...
So it's a pity that they didn't take this approach 5 years ago... a massive own goal, but still a learning point. ONCY at this present time does not have funds to run even x1 phase III, so if they finance Panc by themselves, then mBC is surely not going to happen.
News of a partnership/trial sponsor is pure hope at this point... until their data categorically proves that there is efficacy, the pps will wane, and that means big dilution if they tap the ATM.
fwiw, I think we will see another run next April in anticipation of news at the May AGM on phase III.